Van Aken Elisabeth H, Papeleu Peggy, De Potter Patrick, Bruyneel Erik, Philippé Jan, Seregard Stefan, Kvanta Anders, De Laey Jean-Jacques, Mareel Marc M
Department of Ophthalmology, Laboratory of Experimental Cancerology, Ghent University Hospital, De Pintelaan 185, B-9000 Gent, Belgium.
Invest Ophthalmol Vis Sci. 2002 Mar;43(3):595-602.
To identify in human retinoblastoma and normal retinal tissue the type of cadherin, its relationship with cytoplasmic catenins, and its participation in invasion.
The cadherin/catenin complex was characterized in surgical retinoblastoma specimens from five patients and human retinas from four donor eyes by immunocytochemistry, flow cytometry, and coimmunoprecipitation with antibodies against N-cadherin, alpha-catenin, and beta-catenin, followed by Western blot analysis or autoradiography. Y79 and WERI-Rb-1 retinoblastoma cell lines serve the evaluation of the cadherin/catenin complex in aggregation and collagen type I invasion in vitro. The association of the cadherin/catenin complex with the cytoskeleton was examined by an antibody-capping assay.
In retinoblastoma and normal retina N-cadherin associated with alpha-catenin and beta-catenin but not E- or P-cadherin. The N-cadherin/catenin complex formed a regular, linear, and continuous honeycomb pattern in normal retina that was irregular, clustered, and interrupted in retinoblastoma. The N-cadherin/catenin complex was found also in the retinoblastoma cell lines WERI-Rb and Y79, in which it also showed an irregular pattern. Both cell lines were invasive in collagen type I, and invasion was inhibited by the GC-4 antibody, which functionally neutralizes N-cadherin. Less GC-4 antibody was needed to inhibit invasion of Y79 cells, which expressed N-cadherin at a lower level, than to inhibit invasion of WERI-Rb-1 cells. In both cell lines, antibody capping of the N-cadherin/catenin complex indicated that its linkage with the cytoskeleton were weak or absent.
Retinoblastoma cells, in contrast with normal retina, express an N-cadherin/catenin complex that is irregularly distributed and weakly linked to the cytoskeleton. In retinoblastoma, this complex acts as an invasion promoter.
在人类视网膜母细胞瘤和正常视网膜组织中鉴定钙黏蛋白的类型、其与细胞质连环蛋白的关系及其在侵袭中的作用。
通过免疫细胞化学、流式细胞术以及用抗N-钙黏蛋白、α-连环蛋白和β-连环蛋白的抗体进行共免疫沉淀,随后进行蛋白质印迹分析或放射自显影,对5例患者手术切除的视网膜母细胞瘤标本和4只供体眼的人类视网膜中的钙黏蛋白/连环蛋白复合物进行表征。Y79和WERI-Rb-1视网膜母细胞瘤细胞系用于评估钙黏蛋白/连环蛋白复合物在体外聚集和I型胶原侵袭中的情况。通过抗体封端试验检测钙黏蛋白/连环蛋白复合物与细胞骨架的关联。
在视网膜母细胞瘤和正常视网膜中,N-钙黏蛋白与α-连环蛋白和β-连环蛋白相关联,而与E-钙黏蛋白或P-钙黏蛋白无关。N-钙黏蛋白/连环蛋白复合物在正常视网膜中形成规则、线性且连续的蜂窝状模式,而在视网膜母细胞瘤中则不规则、聚集且中断。在视网膜母细胞瘤细胞系WERI-Rb和Y79中也发现了N-钙黏蛋白/连环蛋白复合物,其在其中也呈现不规则模式。两种细胞系均能侵袭I型胶原,且侵袭受到功能性中和N-钙黏蛋白的GC-4抗体的抑制。抑制Y79细胞(其N-钙黏蛋白表达水平较低)的侵袭所需的GC-4抗体比抑制WERI-Rb-1细胞的侵袭所需的抗体少。在两种细胞系中,N-钙黏蛋白/连环蛋白复合物的抗体封端表明其与细胞骨架的连接较弱或不存在。
与正常视网膜相比,视网膜母细胞瘤细胞表达不规则分布且与细胞骨架连接较弱的N-钙黏蛋白/连环蛋白复合物。在视网膜母细胞瘤中,这种复合物起到侵袭促进剂的作用。